Published in Cell Cycle on August 15, 2006
Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer (2007) 6.58
The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities. Cell Cycle (2006) 1.34
Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis (2007) 1.23
Dormancy of metastatic melanoma. Pigment Cell Melanoma Res (2009) 1.19
Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance. Breast Cancer Res (2008) 1.09
Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. Int J Radiat Oncol Biol Phys (2008) 0.92
Why victory in the war on cancer remains elusive: biomedical hypotheses and mathematical models. Cancers (Basel) (2011) 0.80
A cellular automaton model for tumor dormancy: emergence of a proliferative switch. PLoS One (2014) 0.79
Effects of Surgery and Chemotherapy on Metastatic Progression of Prostate Cancer: Evidence from the Natural History of the Disease Reconstructed through Mathematical Modeling. Cancers (Basel) (2011) 0.77
Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering? BMC Cancer (2010) 0.76
Effect of surgical wound fluids after intraoperative electron radiotherapy on the cancer stem cell phenotype in a panel of human breast cancer cell lines. Oncol Lett (2016) 0.75
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res (2002) 3.54
HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci U S A (2004) 3.43
Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo. Clin Cancer Res (2002) 2.07
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status. Breast Cancer Res (2007) 1.78
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues. Proc Natl Acad Sci U S A (2006) 1.61
Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors. Breast Cancer Res Treat (2002) 0.87
Circulating tumor cells in breast cancer: fiction or reality? J Clin Oncol (2008) 0.83